Davidson Michael H.

Director at NewAmsterdam Pharma Co N.V. · on record since Dec 29, 2023
Chief Executive Officer at NewAmsterdam Pharma Co N.V. · on record since Dec 29, 2023
Director at Silence Therapeutics plc · on record since Jan 6, 2025
Executive VP & CMO at Omthera Pharmaceuticals, Inc. · on record since Apr 17, 2013
10% owner at Omthera Pharmaceuticals, Inc. · on record since Apr 11, 2013
Director at TENAX THERAPEUTICS, INC. · on record since Jun 15, 2021
Director at BioAge Labs, Inc. · on record since Jun 12, 2026
Director at LISATA THERAPEUTICS, INC. · on record since Aug 12, 2020

Insider trading activity of Davidson Michael H.

Transactions on record: 54; since Apr 17, 2013

Open-market buys: 5; $494.1K

Open-market sells: 10; $25.3M

Companies traded: 6; last filing Sep 15, 2026

Figures computed from official regulatory filings — .

Companies where Davidson Michael H. has traded

NewAmsterdam Pharma Co N.V.31 tx · $25.9M · Sep 15, 2026
BioAge Labs, Inc.4 tx · Jun 12, 2026
TENAX THERAPEUTICS, INC.10 tx · Jan 13, 2026
Silence Therapeutics plc1 tx · Jan 6, 2025
LISATA THERAPEUTICS, INC.4 tx · $219.9K · Jan 12, 2022
Omthera Pharmaceuticals, Inc.4 tx · Jul 18, 2013

Track record of Davidson Michael H.

Statistical track record

Free account

Open-market buys: 7

Last buy: Sep 14, 2026

Win rates, median returns and the proven-insider analysis come with a free account.

Transaction history of Davidson Michael H.

Co-insiders of Davidson Michael H.

This page republishes public regulatory disclosures.

Company	Filed	Type	Qty	Price	Value · USD	Signals	Src
NewAmsterdam Pharma Co N.V.Listing on record	Sep 15, 2026	Buy	10,000	22.65 USD	$226.5K	conv 71Unusual sizeFirst in 12mo	SEC
BioAge Labs, Inc.Listing on record	Jun 12, 2026	AwardD (derivative)	22,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
NewAmsterdam Pharma Co N.V.Listing on record	Mar 2, 2026	ExerciseD (derivative)	-443,707	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
NewAmsterdam Pharma Co N.V.Listing on record	Mar 2, 2026	Sell	-443,707	33.25 USD	$14.8M	Unusual size	SEC
NewAmsterdam Pharma Co N.V.Listing on record	Mar 2, 2026	Exercise	443,707	—	n/a (No price was disclosed in the filing)		SEC
NewAmsterdam Pharma Co N.V.Listing on record	Feb 26, 2026	Exercise	58,253	—	n/a (No price was disclosed in the filing)		SEC
NewAmsterdam Pharma Co N.V.Listing on record	Feb 26, 2026	ExerciseD (derivative)	-58,253	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
NewAmsterdam Pharma Co N.V.Listing on record	Feb 26, 2026	ExerciseD (derivative)	-183,332	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
NewAmsterdam Pharma Co N.V.Listing on record	Feb 26, 2026	Exercise	183,332	—	n/a (No price was disclosed in the filing)		SEC
NewAmsterdam Pharma Co N.V.Listing on record	Feb 26, 2026	Sell	-61,547	36.13 USD	$2.2M		SEC
NewAmsterdam Pharma Co N.V.Listing on record	Feb 26, 2026	Sell	-10,436	35.96 USD	$375.3K		SEC
NewAmsterdam Pharma Co N.V.Listing on record	Feb 26, 2026	Sell	-165,408	33.63 USD	$5.6M	Unusual size	SEC
NewAmsterdam Pharma Co N.V.Listing on record	Feb 26, 2026	Exercise	64,708	—	n/a (No price was disclosed in the filing)		SEC
NewAmsterdam Pharma Co N.V.Listing on record	Feb 26, 2026	ExerciseD (derivative)	-64,708	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
NewAmsterdam Pharma Co N.V.Listing on record	Feb 26, 2026	Sell	-1,300	36.68 USD	$47.7K		SEC
NewAmsterdam Pharma Co N.V.Listing on record	Feb 26, 2026	Sell	-46,517	35.11 USD	$1.6M		SEC
NewAmsterdam Pharma Co N.V.Listing on record	Feb 26, 2026	Sell	-3,161	36.46 USD	$115.3K		SEC
NewAmsterdam Pharma Co N.V.Listing on record	Feb 26, 2026	Sell	-17,924	34.44 USD	$617.3K		SEC
TENAX THERAPEUTICS, INC.Listing on record	Jan 13, 2026	AwardD (derivative)	30,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
NewAmsterdam Pharma Co N.V.Listing on record	Jan 9, 2026	AwardD (derivative)	364,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
NewAmsterdam Pharma Co N.V.Listing on record	Jan 9, 2026	Sell	-11,582	—	n/a (No price was disclosed in the filing)		SEC
NewAmsterdam Pharma Co N.V.Listing on record	Jan 9, 2026	Award	81,000	—	n/a (No price was disclosed in the filing)		SEC
TENAX THERAPEUTICS, INC.Listing on record	Jul 3, 2025	AwardD (derivative)	80,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
BioAge Labs, Inc.Listing on record	Jun 9, 2025	AwardD (derivative)	22,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
NewAmsterdam Pharma Co N.V.Listing on record	Mar 28, 2025	Exercise	38,394	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC

Company	Filed	Type	Qty	Price	Value · USD	Signals	Src
NewAmsterdam Pharma Co N.V.Listing on record	Sep 15, 2026	Buy	10,000	22.65 USD	$226.5K	conv 71Unusual sizeFirst in 12mo	SEC
BioAge Labs, Inc.Listing on record	Jun 12, 2026	AwardD (derivative)	22,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
NewAmsterdam Pharma Co N.V.Listing on record	Mar 2, 2026	ExerciseD (derivative)	-443,707	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
NewAmsterdam Pharma Co N.V.Listing on record	Mar 2, 2026	Sell	-443,707	33.25 USD	$14.8M	Unusual size	SEC
NewAmsterdam Pharma Co N.V.Listing on record	Mar 2, 2026	Exercise	443,707	—	n/a (No price was disclosed in the filing)		SEC
NewAmsterdam Pharma Co N.V.Listing on record	Feb 26, 2026	Exercise	58,253	—	n/a (No price was disclosed in the filing)		SEC
NewAmsterdam Pharma Co N.V.Listing on record	Feb 26, 2026	ExerciseD (derivative)	-58,253	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
NewAmsterdam Pharma Co N.V.Listing on record	Feb 26, 2026	ExerciseD (derivative)	-183,332	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
NewAmsterdam Pharma Co N.V.Listing on record	Feb 26, 2026	Exercise	183,332	—	n/a (No price was disclosed in the filing)		SEC
NewAmsterdam Pharma Co N.V.Listing on record	Feb 26, 2026	Sell	-61,547	36.13 USD	$2.2M		SEC
NewAmsterdam Pharma Co N.V.Listing on record	Feb 26, 2026	Sell	-10,436	35.96 USD	$375.3K		SEC
NewAmsterdam Pharma Co N.V.Listing on record	Feb 26, 2026	Sell	-165,408	33.63 USD	$5.6M	Unusual size	SEC
NewAmsterdam Pharma Co N.V.Listing on record	Feb 26, 2026	Exercise	64,708	—	n/a (No price was disclosed in the filing)		SEC
NewAmsterdam Pharma Co N.V.Listing on record	Feb 26, 2026	ExerciseD (derivative)	-64,708	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
NewAmsterdam Pharma Co N.V.Listing on record	Feb 26, 2026	Sell	-1,300	36.68 USD	$47.7K		SEC
NewAmsterdam Pharma Co N.V.Listing on record	Feb 26, 2026	Sell	-46,517	35.11 USD	$1.6M		SEC
NewAmsterdam Pharma Co N.V.Listing on record	Feb 26, 2026	Sell	-3,161	36.46 USD	$115.3K		SEC
NewAmsterdam Pharma Co N.V.Listing on record	Feb 26, 2026	Sell	-17,924	34.44 USD	$617.3K		SEC
TENAX THERAPEUTICS, INC.Listing on record	Jan 13, 2026	AwardD (derivative)	30,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
NewAmsterdam Pharma Co N.V.Listing on record	Jan 9, 2026	AwardD (derivative)	364,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
NewAmsterdam Pharma Co N.V.Listing on record	Jan 9, 2026	Sell	-11,582	—	n/a (No price was disclosed in the filing)		SEC
NewAmsterdam Pharma Co N.V.Listing on record	Jan 9, 2026	Award	81,000	—	n/a (No price was disclosed in the filing)		SEC
TENAX THERAPEUTICS, INC.Listing on record	Jul 3, 2025	AwardD (derivative)	80,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
BioAge Labs, Inc.Listing on record	Jun 9, 2025	AwardD (derivative)	22,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
NewAmsterdam Pharma Co N.V.Listing on record	Mar 28, 2025	Exercise	38,394	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC